Showing results (1-10 of 429) with videos related to
Sort By:
Pageof 43
Onkologie|April 8, 2006
Proteasome inhibition: novel therapy for multiple myelomaJonathan L Kaufman, Sagar LonialOncology (Williston Park, N.Y.)|November 29, 2013
Non-secretory myeloma: a clinician's guideSagar Lonial, Jonathan L KaufmanClinical Lymphoma & Myeloma|March 2, 2006
Novel treatment approaches for patients with multiple myelomaRajni Sinha, Jonathan L Kaufman, Sagar LonialClinical Lymphoma & Myeloma|May 27, 2008
Multiple myeloma presenting with advanced renal failure: a case report and new treatment optionsS Pierson Gladney, Sagar Lonial, Jonathan L KaufmanClinical Lymphoma, Myeloma & Leukemia|June 22, 2013
Histone deacetylase inhibitors in multiple myeloma: rationale and evidence for their use in combination therapyJonathan L Kaufman, Claire Fabre, Sagar Lonial, et al.Clinical Lymphoma, Myeloma & Leukemia|August 2, 2017
High-risk Multiple Myeloma: Definition and ManagementNisha S Joseph, Silvia Gentili, Jonathan L Kaufman, et al.Cancer|June 22, 2010
Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple myeloma: a retrospective studyJonathan L Kaufman, Ajay Nooka, Mark Vrana, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Perifosine synergistically enhances TRAIL-induced myeloma cell apoptosis via up-regulation of death receptorsEbenezer David, Rajni Sinha, Jing Chen, et al.Medical Oncology (Northwood, London, England)|December 17, 2009
Future directions in immunomodulatory therapySagar LonialPageof 43